Figure 4.
Metabolic pathways upregulated by CD40 or BCR were mirrored by IBR. Volcano plots of significantly increased metabolites in baseline+CD40 vs baseline cells (A) or 3-month IBR treatment+BCR vs baselineUN (B). Statistical analyses were performed with paired Student t test with selective threshold P value < .1 and fold change (FC) > 2 (n = 8). (C) Venn diagram showing the metabolic pathways upregulated by CD40 or BCR stimulation. Pathway analysis was performed from significantly increased metabolites in baseline+CD40 vs baseline or 3-month IBR treatment+BCR vs baseline (n = 8) using MetaboAnalyst software (https://www.metaboanalyst.ca/). (D) Volcano plot of significantly decreased metabolites by 3-month IBR treatmentvs baseline. Statistical analyses were performed with paired Student t test with threshold P value < .1 and FC > 2 (n = 8). Top 15 pathways upregulated by CD40 (E) or BCR (F), which were downregulated by IBR treatment. ETC, electron transport chain.

Metabolic pathways upregulated by CD40 or BCR were mirrored by IBR. Volcano plots of significantly increased metabolites in baseline+CD40 vs baseline cells (A) or 3-month IBR treatment+BCR vs baselineUN (B). Statistical analyses were performed with paired Student t test with selective threshold P value < .1 and fold change (FC) > 2 (n = 8). (C) Venn diagram showing the metabolic pathways upregulated by CD40 or BCR stimulation. Pathway analysis was performed from significantly increased metabolites in baseline+CD40 vs baseline or 3-month IBR treatment+BCR vs baseline (n = 8) using MetaboAnalyst software (https://www.metaboanalyst.ca/). (D) Volcano plot of significantly decreased metabolites by 3-month IBR treatmentvs baseline. Statistical analyses were performed with paired Student t test with threshold P value < .1 and FC > 2 (n = 8). Top 15 pathways upregulated by CD40 (E) or BCR (F), which were downregulated by IBR treatment. ETC, electron transport chain.

Close Modal

or Create an Account

Close Modal
Close Modal